GlassScriptPhysician profile
James D Kim
NPI 1255657151
$4,215.49
in general payments reported to CMS, 2019-2025
17 companies · $1,338 in 2025
The $1,338 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $198 · 2021: $269 · 2022: $188 · 2023: $851 · 2024: $884 · 2025: $1,338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,072.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $740.65 | 2023-2025 | Izervay |
| Regeneron Healthcare Solutions, INC. | $588.34 | 2019-2025 | Eylea Hd, Eylea |
| Abbvie INC. | $555.40 | 2023-2025 | |
| Genentech USA, INC. | $431.77 | 2019-2025 | Vabysmo, Susvimo |
| Apellis Pharmaceuticals, INC. | $379.95 | 2023-2025 | Syfovre |
| Harrow Eye, LLC | $299.06 | 2024-2025 | Iheezo, Triesence |
| Alimera Sciences, INC. | $224.16 | 2023-2024 | Iluvien, Yutiq |
| Novartis Pharmaceuticals Corporation | $220.36 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $212.74 | 2019 | |
| Ani Pharmaceuticals, INC. | $166.42 | 2025 | Purified Cortrophin Gel, Iluvien |
| Alcon Vision LLC | $125.13 | 2019-2022 | |
| Allergan, INC. | $111.03 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $63.87 | 2022 | |
| Aerie Pharmaceuticals, INC. | $40.04 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $30.84 | 2021-2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyepoint US, INC. | $20.00 | 2023 | |
| Biotissue Holdings INC. | $5.73 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.